Expanding veterinary therapeutic access

Expanding access to HIV prevention

Background The expanding HIV/AIDS epidemic represents one of the greatest threats to human health and international development today, and strengthening the global response is imperative. Despite recent progress in expanding access to HIV/AIDS treatment [1], the world continues to severely under-invest in efforts to fight HIV/AIDS, missing a tremendous opportunity to change the course of the ep...

Expanding Therapeutic Horizons of Bevacizumab

Background: In the past few years there has been an increased interest in the repurposing of already approved pharmacotherapies for other uses. Bevacizumab is the most widely off-label used antiangiogenic in retinal ophthalmology, recently highlighting new targets in other ocular disorders. Objective: The objective of this review is to evaluate the evidence and discuss the rationale behind the ...

Irish Veterinary Journal goes open access

As Editor-in-Chief, I am delighted to announce the relaunch of Irish Veterinary Journal with BioMed Central, The Open Access Publisher, as part of their increasing veterinary portfolio. This is indeed an historical moment in the history of Irish Veterinary Journal, which was first published in November 1946. In this electronic age that we live in, it is interesting to note that the publication ...

Expanding global access to phantom pain care

The Expanding Therapeutic Perspective of CCR5 Blockade

CCR5 and its interaction with chemokine ligands have been crucial for understanding and tackling HIV-1 entry into target cells. However, over time, CCR5 has witnessed an impressive transition from being considered rather unimportant in physiology and pathology to becoming central in a growing number of pathophysiological conditions. It now turns out that the massive efforts devoted to combat HI...